Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,268 | Dovepress* | 8,124+ | 1,519 | 9,643 | |
PubMed Central* | 1,144 | 423 | 1,567 | ||
Totals | 9,268 | 1,942 | 11,210 | ||
*Since 15 February 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed and Google Scholar